Emerging gonadotropin-releasing hormone agonists

Author： Beyer Daniel Alexander   Amari Feriel   Thill Marc   Schultze-Mosgau Askan   Al-Hasani Safaa   Diedrich Klaus   Griesinger Georg  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.2, 2011-06, pp. : 323-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gonadotropin-releasing hormone agonists in breast cancer

By  

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists

By Schultze-Mosgau Askan   Griesinger Georg   Altgassen Christopher   von Otte Soeren   Hornung Daniela   Diedrich Klaus  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1085-1097

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonists

By Herbst K.L.  

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 660-666

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonists reviewed

By  

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer

By Saylor Philip J.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite